Projects per year
Organisation profile
Organisation profile
Taipei Municipal Wan Fang Hospital, as a private management of public hospital, has been operating by Taipei Medical University since 1997.
Wan Fang Hospital lays emphasis on high quality medical service comprehensively; moreover, it has obtained the certification of Medical center level in 7 years and has received many awards since operated. Honorably, Wan Fang Hospital becomes the first hospital to get the accreditation of JCI for four times in 2015. That’s proved quality of service is our pride again.
From the beginning, our hospital visions were, to treat patients with respect, become a center of integrative medicine and provide comprehensive care for all and provide community-oriented service. As an internationally renowned university hospital, Wan Fang Hospital is totally dedicated to provide highest quality of care to our patients.
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Isao Aoi
- Taipei Municipal Wanfang Hospital - Visiting Staff
- Taipei Neuroscience Institute - Member
Person: Researcher
-
Kuan-Jen Bai
- School of Respiratory Therapy - Professor
- Division of Pulmonary Medicine - Joint-Appointment Professor
- Taipei Municipal Wanfang Hospital - Visiting Staff
- TMU Research Center of Thoracic Medicine - Member
Person: Researcher
-
Paul Chan
- Taipei Municipal Wanfang Hospital - Visiting Staff
- Taipei Heart Institute (THI), Taipei Medical University - Member
Person: Researcher
-
併用酵母硒和魚油藉由調控NOXA和MCL-1以增強BCL-2抑制劑venetoclax的療效
Yao, C.-J. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
臨床深度推論之醫療專用大型語言模型開發及商業化服務計畫
Li, Y.-C. (PI)
1/1/25 → 12/31/25
Project: A - Government Institution › f - Other (Funded by Government)
-
製備褐藻素奈米粒子於放射性癌症治療
Wu, S.-Y. (PI)
Project: C - Project of Alliance › m - National Taiwan University of Science and Technology
Research output
-
A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer
Dung, P. V. T., Chen, W. Y., Liu, M. K., Yeh, S. D., Kajla, G., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Chen, C. S., Beltran, H., Wen, Y. C. & Liu, Y. N., Jan 2026, In: Neoplasia (United States). 71, 101251.Research output: Contribution to journal › Article › peer-review
Open Access -
Plasmon-activated water reduces amyloid-β42 aggregation and exhibits neuroprotective potential in Alzheimer’s disease
Chiang, C. I., Liu, C. C., Hao, P. J., Chou, C. M., Chu, C. Y., Liu, E. H., Liu, C. Y., Lee, Y. L. A., Hu, C. J., Liu, Y. C. & Cheng, C. H., Apr 2026, In: Journal of the Taiwan Institute of Chemical Engineers. 181, 106507.Research output: Contribution to journal › Article › peer-review
-
Potassium channel dysfunction and distinct sensory axonal profiles in painful type 2 diabetes
Lin, C. S. Y., Tani, J., Hsu, T. W., Lin, Y. C., Liu, Y. R. & Sung, J. Y., Jan 2026, In: Clinical Neurophysiology. 182, 2111450.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
A 12-month, prospective, observational study of ranibizumab in treatment-naïve Taiwanese patients with neovascular age-related macular degeneration: the RACER study
Wu, W.-C. (Creator), Chen, J.-T. (Contributor), Tsai, C.-Y. (Creator), Wu, C.-L. (Creator), Cheng, C.-K. (Contributor), Shen, Y.-D. (Contributor), Tsai, A. (Creator) & Wu, P.-C. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5219755.v1, https://springernature.figshare.com/collections/A_12-month_prospective_observational_study_of_ranibizumab_in_treatment-na_ve_Taiwanese_patients_with_neovascular_age-related_macular_degeneration_the_RACER_study/5219755/1
Dataset
-
Additional file 2: Table S1 of Health system delay among patients with tuberculosis in Taiwan: 2003â 2010
Chen, C.-C. (Contributor), Chiang, C.-Y. (Contributor), Pan, S.-C. (Contributor), Wang, J.-Y. (Contributor) & Lin, H.-H. (Contributor), Unknown Publisher, Nov 2 2015
DOI: 10.6084/m9.figshare.c.3600383_d5.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_Table_S1_of_Health_system_delay_among_patients_with_tuberculosis_in_Taiwan_2003_2010/4330748/1
Dataset
-
Supplementary Material for: The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme
Lee, P.-Y. (Creator), Chen, C.-L. (Creator), Lin, Z.-Z. (Creator), Cheng, A.-L. (Creator), Chen, E.I.-T. (Creator), Whang-Peng, J. (Creator) & Huang, C.-Y. F. (Contributor), Karger Publishers, 2013
DOI: 10.6084/m9.figshare.5124601.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_The_Aurora_Kinases_Inhibitor_VE-465_is_a_Novel_Treatment_for_Glioblastoma_Multiforme/5124601/1
Dataset